Alan D. Adams - Concepedia

Author

Alan D. Adams

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Alan D Adams, Alan D. Adams

Publications

935

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Alan D. Adams is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, biochemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	8	8	617
2	Medicine	6	6	570
3	Engineering	5	5	114
4	Natural Sciences	4	4	383
5	Health Sciences	1	1	143

Alan D. Adams

Publications

928

Citations

H-Index

Page 1

	Year	Citations
Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective Modulator Joel P. Berger, Ann Petro, Karen L. MacNaul, Molecular Endocrinology Lipid PeroxidationMolecular BiologyRedox BiologyOxidative StressMetabolic Syndrome	2003	321
Different roles of liver X receptor α and β in lipid metabolism: Effects of an α-selective and a dual agonist in mice deficient in each subtype Erik Lund, Laurence B. Peterson, Alan D. Adams, Biochemical Pharmacology Molecular PharmacologyMolecular PhysiologyBiochemistryMedicineLiver Physiology	2005	143
A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux Carl P. Sparrow, Joanne Baffic, My‐Hanh Lam, Journal of Biological Chemistry	2002	121
Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation S.M. Soisson, Gopalakrishnan Parthasarathy, Alan D. Adams, Proceedings of the National Academy of Sciences	2008	90
Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists Alan D. Adams, Winston Yuen, Zao Hu, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicineMechanism Of ActionHuman Ppar γ	2003	37
Miniaturization of Cell-Based <i>β</i> -Lactamase-Dependent FRET Assays to Ultra-High Throughput Formats to Identify Agonists of Human Liver X Receptors Jayne Chin, Alan D. Adams, Aileen Bouffard, Assay and Drug Development Technologies	2003	33
Design of potent and selective GPR119 agonists for type II diabetes Jason W. Szewczyk, John J. Acton, Alan D. Adams, Bioorganic & Medicinal Chemistry Letters Diabetes ManagementBiochemistryFunctional SelectivityMedicineDiabetes	2010	31
Selective steroid chlorinations directed by attached pyridine ester templates Ronald Breslow, Michael Brandl, Juergen Hunger, Journal of the American Chemical Society Molecular SciencesBioorganic ChemistryEngineeringBiochemistryPharmaceutical Chemistry	1987	29
The structure and kinetic reactivity of a pyrrolidine-derived vinylogous urethane lithium enolate Alan D. Adams, R. H. Schlessinger, James R. Tata, The Journal of Organic Chemistry Chemical EngineeringEnantioselective SynthesisEngineeringChemical AnalysisKinetic Reactivity	1986	27
Remarkably similar solution and solid-state structures for two divergently reactive lithium enolates derived from vinylogous urethanes Paul G. Williard, James R. Tata, R. H. Schlessinger, Journal of the American Chemical Society Materials ScienceChemical EngineeringEngineeringSimilar SolutionReactive Lithium	1988	25

Page 1